PT335 – Christopher Dawson & Andrew Galloway – Modernizing Traditional Plant Medicine With Neuroscience and Luxury
Get every episode summarized
Each time Psychedelics Today publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
In this episode, Joe interviews Christopher Dawson & Andrew Galloway: Co-Founders and CEO/COO, respectively, of Dimensions; a company creating retreats blending traditional plant ceremony with modern science and 5-star luxury.
www.psychedelicstoday.com
Get every episode summarized
Each time Psychedelics Today publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Know when Andrew Galloway turns up
Follow Andrew Galloway and once a week we email you every new episode they appeared on — including guest spots the show notes never mention, because we read the transcript.
Follow Andrew GallowayFree. Pick your own day and time.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Psychedelics Today
PT 660 - Josh Lipson & Roman Palitsky: Psychedelic Harms and the Post-Psychedeli...
Psychedelics Today
PT 659 - Megan Bowers & Mikayla Hellwich
Psychedelics Today
PT 658 - Mareesa Stertz – Sphinx Gate Beyond Burning Man: Psychedelic Healing Wi...
Psychedelics Today
PT 657 - Rachel Turetzky PhD & Douglas S. Wingate DTCM: The Eight-Circuit Model,...
Psychedelics Today